Estrogen suppression
PreclinicalSmall molecule
Estrogen suppression is one of 2 small molecule programs targeting Estrogen Deficiency. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1 competitor in Estrogen Deficiency
#DrugCompanyPhaseTrials
1Estrace
Novo NordiskPhase 1
Estrogen suppression
UUniversity of Colorado, Denver
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Estrogen suppression. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Colorado, Denver